Capital Research Global Investors
MDLN

Capital Research Global Investors’s Medline Inc MDLN Stock Holding History

Capital Research Global Investors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03B Buy
23,161,670
+8,377,467
+57% +$370M 0.16% 115
2025
Q4 		$621M Buy
+14,784,203
New +$624M 0.11% 132

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors's MDLN Position: Q1 2026 in Review

Capital Research Global Investors increased its Medline Inc (MDLN) stake by 57% in Q1 2026, buying an estimated $370M and bringing the position to 23,161,670 shares worth $1.03B. The position accounts for 0.16% of the portfolio, ranked #115.

Capital Research Global Investors first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Capital Research Global Investors held 23,161,670 shares of Medline Inc worth $1.03B as of Q1 2026.
  • Capital Research Global Investors bought 8,377,467 Medline Inc shares in Q1 2026, an estimated $370M.
  • Medline Inc made up 0.16% of Capital Research Global Investors's portfolio in Q1 2026, its #115 holding.
  • Capital Research Global Investors first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.